Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118806149 | 11880614 | 9 | F | 201606 | 20160801 | 20151230 | 20160805 | EXP | US-GLAXOSMITHKLINE-US2015183229 | GLAXOSMITHKLINE | 71.70 | YR | F | Y | 56.00000 | KG | 20160805 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118806149 | 11880614 | 1 | PS | VENTOLIN HFA | ALBUTEROL SULFATE | 1 | 1 PUFF(S), UNK | N | LC7J | 20983 | 1 | DF | |||||||
| 118806149 | 11880614 | 2 | SS | VENTOLIN HFA | ALBUTEROL SULFATE | 1 | Respiratory (inhalation) | 2 PUFF(S), BID | N | 20983 | 2 | DF | BID | ||||||
| 118806149 | 11880614 | 3 | SS | VENTOLIN HFA | ALBUTEROL SULFATE | 1 | N | 20983 | |||||||||||
| 118806149 | 11880614 | 4 | SS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 1 PUFF(S), BID | 6ZP5908 | 0 | 1 | DF | INHALATION POWDER | BID | |||||
| 118806149 | 11880614 | 5 | SS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | 0 | INHALATION POWDER | |||||||||||
| 118806149 | 11880614 | 6 | SS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | 0 | INHALATION POWDER | |||||||||||
| 118806149 | 11880614 | 7 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | 0 | ||||||||||||
| 118806149 | 11880614 | 8 | C | MONTELUKAST | MONTELUKAST SODIUM | 1 | 0 | ||||||||||||
| 118806149 | 11880614 | 9 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 0 | ||||||||||||
| 118806149 | 11880614 | 10 | C | METOPROLOL. | METOPROLOL | 1 | 0 | ||||||||||||
| 118806149 | 11880614 | 11 | C | ASPIRIN. | ASPIRIN | 1 | 0 | ||||||||||||
| 118806149 | 11880614 | 12 | C | MIDODRINE TABLET (MIDODRINE) | 2 | 0 | |||||||||||||
| 118806149 | 11880614 | 13 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | 0 | ||||||||||||
| 118806149 | 11880614 | 14 | C | MAGNESIUM | MAGNESIUM | 1 | 0 | ||||||||||||
| 118806149 | 11880614 | 15 | C | DIGOXIN. | DIGOXIN | 1 | 0 | ||||||||||||
| 118806149 | 11880614 | 16 | C | WARFARIN | WARFARIN | 1 | 0 | ||||||||||||
| 118806149 | 11880614 | 17 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118806149 | 11880614 | 1 | Cough |
| 118806149 | 11880614 | 2 | Asthma |
| 118806149 | 11880614 | 3 | Lower respiratory tract congestion |
| 118806149 | 11880614 | 4 | Lower respiratory tract congestion |
| 118806149 | 11880614 | 5 | Asthma |
| 118806149 | 11880614 | 6 | Cough |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118806149 | 11880614 | Cough | |
| 118806149 | 11880614 | Device use error | |
| 118806149 | 11880614 | Drug ineffective |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118806149 | 11880614 | 1 | 2015 | 2016 | 0 | |
| 118806149 | 11880614 | 2 | 201603 | 2016 | 0 | |
| 118806149 | 11880614 | 4 | 20160622 | 0 |